 "Bharat Biotech, Covaxin")
BENGALURU (Reuters) - India's Bharat Biotech said on Wednesday it followed a "step-by-step" approach for the regulatory approval and supply contract of its COVID-19 vaccine in Brazil, and that it has not received advance payments from the Brazilian health ministry.
Brazil's health minister said on Tuesday the country will suspend its $324 million contract for 20 million doses of Bharat Biotech's vaccine after whistleblowers went public with alleged irregularities in the deal.
(Reporting by Anuron Kumar Mitra in Bengaluru, Editing by Sherry Jacob-Phillips)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
